Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma
Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma
Recruiting · NCT06745076 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma | classic Hodgkin lymphoma | Recruiting | Phase 2 | 2026-09-09 | NCT06745076 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Washington | 397 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Irvine | United States | 9 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Fred Hutch/University of Washington Cancer Consortium | Seattle | United States | 140 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Stanford Cancer Institute Palo Alto | Palo Alto | United States | 122 |
| Washington University in St. Louis | St Louis | United States | 79 |